Atlas Trials

Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease

Clinical trial NCT00295165 · TERMINATED

Trial details

NCT number
NCT00295165
Sponsor
Genzyme, a Sanofi Company
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Crohn Disease
Start date
2006-01-01
Primary completion
2006-10-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.